Regulatory Services > Registration
Medicines (MAA)
To bring a medicine to market is a lengthy, time consuming and costly business.
For a new entity the process is seven to twelve years long at an average cost of around two billion pounds (short scale billion) in 2018.
For a generic medicine the cost is approximately half a million pounds with a two-year time frame from start of development to the grant of a Marketing Authorisation.
Early engagement with a regulatory affairs specialist can result in a shorter time frame and less outlay
CambReg has been advising on development programmes and filing for registration for more than 20 years.